| |
74
30. Crane, G. E.
lproniazed (Marsilid) phosphate, a therapeutic agent for mental disorders and
debilltating disease.
Psychiatry Res. Rep. 8, 142-152 (1957).
31. Cusack, B., Nelson, A., Richelson, E.
Binding of antidepressants to human brain receptors: focus on newer Generation
compounds.
Psychopharmacology (Berl). 14, 559-565. (1994)
32. Dalack, G. W., Roose, S. P.
Perspectives on the relationship between cardiovascular disease and affective
disorder.
J. Clin. Psychiatry. 51 (suppl. 7), 4-9. (1990)
33. DeBoer, T., Ruigt, G. S. F., Berendsen, H. H. G.
The a2-selective adrenoreceptor antagonist. Org 3770 (Mirtazapine, Remeron)
enhances noradrenergic and serotonergic transmission.
Hum. Psychopharmacol.10 (suppl. 2), 107-19. (1995)
34. DeMartinis, N. A., Schweizer, E., Rickels, K.
An open trial of nefazodone in high comorbidity panic disorder.
J. Clin. Psychiatry. 57, 245-248. (1996)
35. Depression Guideline Panel.
Depression in Primary Care, Volume 1, Detection and Diagnosis. Clinical
Practice Guideline, Number 5. Rockville, MD: U.S. Department of Health and
Human Services, Agency for Health Care Policy and Research. AHCPR
publication 93-0550. (1993)
36. DiFrancesco, D., Ferroni, A., Mazzanti, M., Tromba, C.
Properties of the hyperpolarizing-activated current (If) in cells isolated from the
rabbit sino-atrial node.
J. Physiol. (Lond). 377, 61-88. (1986)
37. DiFrancesco, D., Tromba, C.
Inhibition of the hyperpolarizing-activated current lf, induced by acetylcholine
in rabbit sino-atrial node myocytes.
J. Physiol. (Lond). 405, 477-491. (1988)
38. DUAG (Danish University Antidepressant Group).
Citalopram: clinical effect profile in comparison with clomipramine. A
controlled multicenter study.
Psychopharmacology. 90,131-8. (1986)
39. Eckberg, D. L.
Parasympathetic cardiovascular control in human disease: a critical review of
methods and results.
Am. J. Physiol. 239(5):H581-93. (1990)
|  |
|
| |
|
|
